Trial · NCT04694183
The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer
NCT04694183, Phase 2, Completed, Quan Wang
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer. Trials, record NCT04694183. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04694183
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer
- NCT number
- NCT04694183
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 37 participants, actual
- Lead sponsor
- Quan Wang
- Conditions
- Stomach Neoplasms
- Interventions
- Camrelizumab, S-1, Oxaliplatin, Paclitaxel
- First posted
- 2021-01-05
- Last updated
- 2024-02-07
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | R0 resection rate | Within 1 month of surgery. | Defined as no residue under the microscope after resection |
| Secondary | Pathologic complete response | Within 1 month of surgery. | The number of people who have achieved complete pathological remission accounted for the proportion of people who met the plan. |
| Secondary | Overall survival | From the start of system therapy to death from any cause. | The time from the start of system therapy to the death of any cause. |
| Secondary | 2-year survival rate | 2 years from the start of system therapy. | Percentage of subjects who are alive without death event at two years. |
| Secondary | Adverse events(all grades） | From the start of system therapy to 6 months after surgery. | Assessed per Common Terminology Criteria for Adverse Events(CTCAE) version 5.0 |
| Secondary | Serious adverse events(≥grade 3） | From the start of system therapy to 6 months after surgery. | Assessed per Common Terminology Criteria for Adverse Events(CTCAE) version 5.0 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04694183
GET https://conductscience.org/api/trials/v1/NCT04694183/registered